Relmada Therapeutics Inc Cash Flow Statement

RLMD $34.23 1.0 3.0%

05/03/21

Speculative, Mid Cap, Sucker Stock

Market Cap £401.7m

Enterprise Value £312.7m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Relmada Therapeutics Inc's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2019
Period End:	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2019-12-31
Period Length:	12M	12M	12M	12M	12M	6M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Prepaid Expenses
Other Assets
Accounts Payable
Accrued Expenses
Other Liabilities
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities

Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.